Device type · CGX
Alkaline Picrate, Colorimetry, Creatinine
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
CGX
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
6
510(k), De Novo and PMA
Adverse event reports
48
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Alkaline Picrate, Colorimetry, Creatinine
- Product code
- CGX
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1225
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for CGX
Latest FDA decisions
K252206 · Decided Jan 9, 2026 · 179 days after receipt
Device type: Alkaline Picrate, Colorimetry, Creatinine (CGX) · Laboratory Medicine & Pathology
K251058 · Decided Nov 26, 2025 · 236 days after receipt
Device type: Alkaline Picrate, Colorimetry, Creatinine (CGX) · Laboratory Medicine & Pathology
Siemens Healthcare Diagnostics, Inc.
K242685 · Decided Dec 4, 2024 · 89 days after receipt
Device type: Alkaline Picrate, Colorimetry, Creatinine (CGX) · Laboratory Medicine & Pathology
3 more FDA decisions with a free account
Reports received
48
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
48
100% of reports
Injury reports
0
0.0% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 3 | 0 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 3 | 0 | 0 | 0 |
| Apr 24 | 2 | 1 | 0 | 0 |
| May 24 | 4 | 0 | 0 | 0 |
| Jun 24 | 2 | 0 | 0 | 0 |
| Jul 24 | 3 | 0 | 0 | 0 |
| Aug 24 | 1 | 0 | 0 | 0 |
| Sep 24 | 2 | 0 | 0 | 0 |
| Oct 24 | 3 | 0 | 0 | 0 |
| Nov 24 | 3 | 0 | 0 | 0 |
| Dec 24 | 3 | 0 | 0 | 0 |
| Jan 25 | 3 | 0 | 0 | 0 |
| Feb 25 | 2 | 0 | 0 | 0 |
| Mar 25 | 4 | 0 | 0 | 0 |
| Apr 25 | 3 | 0 | 0 | 0 |
| May 25 | 6 | 0 | 0 | 0 |
| Jun 25 | 3 | 0 | 0 | 0 |
| Jul 25 | 3 | 0 | 0 | 0 |
| Aug 25 | 3 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 2 | 0 | 0 | 0 |
| Nov 25 | 2 | 0 | 0 | 0 |
| Dec 25 | 5 | 0 | 0 | 0 |
| Jan 26 | 4 | 0 | 0 | 0 |
| Feb 26 | 2 | 0 | 0 | 0 |
| Mar 26 | 3 | 0 | 0 | 0 |
| Apr 26 | 10 | 0 | 0 | 0 |
| May 26 | 3 | 0 | 0 | 0 |
| Jun 26 | 5 | 0 | 0 | 0 |
| Jul 26 | 3 | 0 | 0 | 0 |
| Aug 26 | 2 | 0 | 0 | 0 |
| Sep 26 | 4 | 0 | 0 | 0 |
| Oct 26 | 5 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott18
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results19
- Low Test Results15
- Non Reproducible Results11
3 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions48
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Siemens Healthcare Diagnostics, Inc.
Z-1980-2026 · Started Mar 18, 2026 · Posted by FDA Apr 28, 2026
Reason given: Siemens Healthcare Diagnostics is recalling certain lots of Dimension Creatinine Flex reagent cartridge (Dimension CRE2) because a potential imprecision in the Dimension CRE2 quality control (QC) and patient sample results using lot numbers GA6307 and BA7005 on the Dimension System. This imprecision may lead to...
Cause as FDA categorized it: Under Investigation by firm
- a. ABX PENTRA CREATININE 120CP JAFFE 120/130. Ref: A11A01933. b. Reagent General Chemistry Creatinine Model Number: 1220001933Open, Classified
Mckesson Medical-Surgical Inc. Corporate Office
Z-1586-2022 · Started May 25, 2022 · Posted by FDA Aug 26, 2022
Reason given: Facility Temperature excursions (from June 2021-August 2021) prior to delivery; exposure to higher temperatures may have impacted product effectiveness. All lots received between 06/01/21-9/30/21.
Cause as FDA categorized it: Environmental control
- Atellica CH Chemistry CalibratorTerminated
Siemens Healthcare Diagnostics, Inc.
Z-2431-2020 · Started Jun 5, 2020
Reason given: Calibration errors have been observed with the Total and Direct Bilirubin assays when using Chemistry Calibrator lot 534177 for ADVIA Chemistry and lot 534179 for Atellica CH.
Cause as FDA categorized it: Nonconforming Material/Component
12 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.